News

Reading the news

Product news

News

Now available UPLIZNA®

October 2021

News

Now available OPDIVO®

October 2021

News

Ocular Therapeutix™ announces FDA approval of Supplemental New Drug Application (SNDA) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itching associated with allergic conjunctivitis

October 2021


Media mentions

Media Mention

Physician Practices Post-Pandemic: Q&A with Jenny Sherak, AmerisourceBergen 

Pharmaceutical Executive, Jenny Sherak
July 6, 2021

Media Mention

AmerisourceBergen Commends the Introduction of S. 1909 & H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act, in Congress


June 8, 2021

Media Mention

How COVID-19 Strengthened the Supply Chain and Key Takeaways for the Future

PM360, Heather Zenk, PharmD
May 19, 2021


Press releases

Press Release

WeInfuse launches Distributor Connect Program

July 2021

Press Release

AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses 

June 2021

AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses

Press Release

AmerisourceBergen Launches Accelerate Specialty Network – Nation’s First Specialty-Focused Pharmacy Services Administration Organization 

April 2021